Associate Director – Web Technologies Lead
About the job
- A bachelor's degree or equivalent combination of education and relevant professional experience is required; preferred fields include Information Systems, Computer Science, Software Engineering, Web Development or Web Technologies, Digital Technologies, Information Technology, Business Information Systems, and Engineering or a related technical field.
- Deep expertise with enterprise content management systems such as WordPress, including site architecture, configuration, plugin management, and troubleshooting.
- Deep expertise with web hosting environments such as Kinsta or similar managed hosting platforms.
- Deep expertise in web platform operations, including deployment, release management, environment configuration, and performance optimization.
- Strong working knowledge of web technologies, including HTML, CSS, JavaScript, APIs, and integrations.
- Strong working knowledge of content management system performance optimization, technical search engine optimization fundamentals, caching, and site speed optimization.
- Strong working knowledge of analytics, tracking, and consent management platforms, such as Google Analytics 4, tag management, and privacy tools.
- Strong working knowledge of web security, accessibility including Web Content Accessibility Guidelines, and compliance requirements in regulated environments.
- Familiarity with headless content management system architectures and modern web development frameworks.
- Familiarity with continuous integration and continuous delivery pipelines, version control systems, and development workflows.
- Familiarity with marketing technology integrations, such as customer relationship management, marketing automation, and personalization tools.
- Familiarity with artificial intelligence-enabled web capabilities, automation, and digital experience technologies.
- Proficiency with collaboration and documentation tools such as Teams, SharePoint, and Confluence.
- At least eight years of experience in web technologies, content management system platform management, digital engineering, or marketing technology; biotech, pharmaceutical, or life sciences experience is preferred.
- Proven experience owning and scaling enterprise content management system platforms, such as WordPress, across a global multisite ecosystem.
- Strong understanding of web architecture, hosting environments, performance optimization, and platform operations.
- Demonstrated ability to lead web platform strategy, roadmap development, and operating model design in a complex, regulated environment.
- Experience managing implementation, development, and production partners, including delivery oversight, prioritization, and performance management.
- Experience translating business and digital experience requirements into scalable technical solutions and platform capabilities.
- Strong understanding of web governance, including security, privacy, accessibility, and compliance requirements.
- Experience supporting web integrations across analytics, tagging, consent management, and marketing technology ecosystems.
- Demonstrated ability to establish scalable processes, including release management, intake, prioritization, and global web operations.
- Ability to influence Commercial, Medical, Corporate, and technology teams.
- The position requires minimal to moderate travel, estimated at 5–15%, primarily for key planning sessions, vendor engagements, or major platform milestones.
- Serve as the enterprise platform owner for the global web technology ecosystem, with primary accountability for the content management system, hosting environment, and web platform operations.
- Own the technical roadmap for enterprise web platforms, ensuring alignment with global business priorities, digital strategy, compliance requirements, and scalability needs.
- Ensure the content management system supports a global portfolio of Commercial, Medical, Corporate, and other enterprise web properties.
- Monitor platform performance, stability, security, and scalability to ensure reliable delivery of digital experiences across markets.
- Partner with internal technology teams and external platform partners to plan enhancements, upgrades, integrations, and future-state web capabilities.
- Manage the enterprise content management system environment, including WordPress configuration, site structure, templates, plugins, user access, publishing workflows, and technical standards.
- Oversee the managed hosting environment and ensure processes are in place for uptime, performance, backups, environment management, and deployment readiness.
- Provide hands-on technical troubleshooting for content management system, hosting, site performance, configuration, publishing, and content management issues.
- Establish and maintain standard operating procedures for content management system administration, site updates, releases, issue resolution, and escalation management.
- Ensure platform configurations support efficient content management, localization, site maintenance, and global reuse across web properties.
- Oversee planning, execution, and delivery of web development, production updates, enhancements, migrations, and new site launches.
- Define and manage release management processes, including intake, prioritization, testing, approvals, deployment, and post-launch validation.
- Ensure technical requirements are documented clearly and translated into actionable implementation details for development and production partners.
- Support structured quality assurance, user acceptance testing, defect resolution, and readiness checks before launch or deployment.
- Maintain visibility into development backlogs, timelines, risks, dependencies, and issue resolution across active web initiatives.
- Partner with Commercial, Medical, Corporate, Digital Strategy & Enablement, and other stakeholder teams to understand web needs and business objectives.
- Translate business, content, and digital experience requirements into technical specifications, platform capabilities, and implementation plans.
- Advise stakeholders on content management system functionality, web platform capabilities, technical feasibility, dependencies, and recommended solutions.
- Support technical project management for web initiatives, including requirements gathering, scope definition, timeline coordination, risk identification, and delivery tracking.
- Ensure solutions are scalable, maintainable, globally consistent, and aligned to enterprise web standards.
- Establish and maintain governance standards, operating procedures, and best practices for enterprise web platform management.
- Define processes for website intake, technical review, prioritization, environment management, production releases, and ongoing site maintenance.
- Ensure web properties follow approved enterprise standards for content management system usage, hosting, accessibility, privacy, security, analytics, search engine optimization, and content management.
- Partner with internal teams to clarify roles and responsibilities across website ownership, content ownership, technical support, approvals, and production execution.
- Define and scale a standardized, templated web delivery model that enables modular site development, reusable components, and consistent implementation across global web properties.
- Maintain documentation, process guides, technical standards, and enablement materials to support consistent web operations globally.
- Ensure web platforms and related processes support enterprise security, privacy, accessibility, and compliance requirements.
- Partner with Information Security, Privacy, Legal, Compliance, and technology teams to assess and address web-related risks.
- Support implementation of security standards, consent management, cookie compliance, accessibility requirements, and approved third-party technologies.
- Monitor technical risks related to plugins, integrations, platform changes, vulnerabilities, environment configuration, and production releases.
- Ensure web operating procedures support appropriate documentation, approvals, validation, and audit readiness in a regulated environment.
- Support integration of web platforms with analytics, tagging, consent management, marketing technologies, customer relationship management, search, and other digital ecosystem tools.
- Partner with Data & Analytics, Digital Strategy & Enablement, and tagging and taxonomy teams to ensure web properties support measurement, reporting, and optimization needs.
- Ensure web implementations support appropriate tracking, data capture, content findability, search engine optimization, and performance measurement requirements.
- Evaluate technical dependencies across content management systems, hosting, analytics, forms, application programming interfaces, and third-party services to ensure a connected and reliable web ecosystem.
- Support improvements that enable better site performance, operational efficiency, content reuse, and digital experience delivery.
- Continuously evaluate emerging content management system, web, hosting, automation, artificial intelligence, and digital experience technologies that may improve the global web ecosystem.
- Identify opportunities to modernize web operations, reduce manual effort, improve speed to market, and increase consistency across global web properties.
- Drive continuous improvement of content management system processes, technical standards, documentation, release management, and partner delivery models.
- Recommend enhancements to improve scalability, performance, security, accessibility, and user experience across enterprise web platforms.
- Support the long-term evolution of the web technology strategy in alignment with enterprise architecture, digital innovation, and global business needs.
- May directly manage and develop technical roles, including a Web Technical Project Manager or similar resources supporting web platform delivery.
- Provide direction and oversight to cross-functional contributors and project resources supporting web initiatives, including prioritization, delivery coordination, and issue resolution.
- Establish accountability across internal and external teams for delivery, timelines, technical quality, and operational excellence across global web properties.
- A master's degree (MBA, Master of Science, or similar) is preferred.
- Experience in biotech, pharmaceutical, or life sciences is preferred.
About the company
BeOne Medicines develops and commercializes cancer therapies for patients worldwide, focusing on hematologic cancers and solid tumors. Its products, including Brukinsa, are sold globally and supported by licensing partnerships, with internal R&D and clinical development driving a broad late-stage pipeline. BeOne differentiates itself by leveraging a large-scale clinical trial network and cost-efficient global drug development to achieve high margins while pursuing large-market indications. The company aims to expand into immunology and solid tumors while maintaining strong investment in R&D to make high-impact, accessible oncology treatments available in more than 45 countries.
Company Size
1,001-5,000
Company Stage
IPO
Headquarters
Dongcheng District, China
Founded
2010
Get referred to BeOne
See people who can refer or advise you
Simplify's Take
What believers are saying
- August 25, 2026 FDA approval expanded TEVIMBRA in first-line HER2-positive gastroesophageal cancer.
- August 31, 2026 Phase 3 survival data strengthened ZIIHERA-containing regimens.
- Q2 2026 revenue hit $1.7 billion; management raised 2026 guidance to $6.8 billion.
What critics are saying
- BeOne accepted developed-market pricing parity and Medicaid rebates on future U.S. approvals.
- Zydus' BRUKINSA ANDA lawsuit targets patents; a 2034 composition patent remains the fortress.
- AbbVie's trade-secrets case over BGB-16673 still threatens the BTK-degrader franchise.
What makes BeOne unique
- BeOne built 35-plus assets and 93 trials across 1,100 U.S. sites by September 2026.
- BRUKINSA dominates revenue, with 2026 global sales above $1.2 billion quarterly.
- Hopewell, New Jersey gives BeOne U.S. manufacturing, R&D, and packaging capacity.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
401(k) Retirement Plan
Wellness Program
Paid Vacation
Growth & Insights and Company News
6 month growth
8%1 year growth
-6%2 year growth
-1%Onco360, an independent specialty pharmacy, has been selected as a pharmacy partner by BeOne Medicines for Beqalzi (sonrotoclax). The drug is indicated for treating adults with relapsed or refractory mantle cell lymphoma after at least two lines of systemic therapy, including a Bruton's tyrosine kinase inhibitor. Beqalzi is a BCL-2 protein inhibitor. In a Phase 1/2 study of 103 adult patients with relapsed/refractory mantle cell lymphoma, the drug achieved an overall response rate of 52.4%, with a median time to response of 1.9 months. The median duration of response was 15.8 months. Onco360 is headquartered in Louisville, Kentucky, and operates as a flagship brand of PharMerica Corporation.
BeOne Medicines secured an exemption from Section 232 pharmaceutical tariffs through a voluntary agreement with the US government. The deal recognises over $1 billion in US manufacturing investment, including a $300 million expansion in Hopewell, New Jersey. The exemption protects BeOne from import duties on patented pharmaceuticals and ingredients. However, the company committed to pricing future FDA-approved medicines in line with other developed markets and participating in the Medicaid GENEROUS Model, which uses supplemental rebates. The Hopewell expansion will add small-molecule manufacturing and packaging capacity, creating approximately 120 full-time jobs. The facility will support a portfolio of more than 35 assets. Whilst the tariff exemption reduces supply-chain risk, international reference pricing commitments could limit pricing flexibility for future oncology medicines. Neither the tariff savings nor the financial impact of pricing concessions was disclosed.
Revolution Medicines has partnered with BeOne Medicines in a multi-part collaboration combining BeOne's oncology assets with Revolution's four clinical RAS(ON) inhibitors. The August 2026 deal grants BeOne exclusive development and commercialisation rights in select Asian markets and commits BeOne to fund a global Phase 3 trial. Revolution Medicines reported a net loss of $644.37 million in Q2 2026 and $1.1 billion over six months. The company currently generates no revenue but projects $2.3 billion in revenue and $402.5 million in earnings by 2029. The partnership shifts near-term risk by offloading Phase 3 costs whilst providing access to milestone and royalty potential. However, the core investment case remains unchanged: regulatory progress and commercialisation of daraxonrasib, with trial execution and spending presenting the biggest risks.
BeOne Medicines reported second-quarter revenue of $1.7 billion, up 30% year over year, with GAAP earnings per ADS rising 144% to $2.05. The company's BTK inhibitor BRUKINSA generated more than $1.2 billion in global sales, increasing 31% from the prior year. The company raised its 2026 revenue guidance to CNY 6.6 billion–CNY 6.8 billion and expects GAAP operating income of CNY 1 billion–CNY 1.1 billion. Free cash flow doubled year over year to CNY 435 million. BeOne received FDA approval for Beqalzi in relapsed or refractory mantle cell lymphoma and reported positive Phase III results for a chemotherapy-free BRUKINSA regimen. US BRUKINSA sales totalled $893 million, up 31%, driven by demand in chronic lymphocytic leukaemia and non-CLL indications.
John Oyler, chief executive officer of BeOne Medicines AG, sold 109,713 American Depositary Shares worth $34.6 million on 20 and 21 July 2026, according to SEC filings. The transactions were executed under a Rule 10b5-1 trading plan adopted in March 2026. Despite the sale, Oyler retains a substantial ownership position exceeding 50.4 million total shares through various holdings. These include 28.2 million shares held through Oyler Investment LLC and 9.5 million shares in a Roth IRA account. The shares were sold at a weighted average price of $315.28. BeOne Medicines is a commercial-stage oncology biopharmaceutical company with $5.7 billion in trailing twelve-month revenue and a market capitalisation of $34.2 billion.